Silk Road Medical, Inc. (NASDAQ:SILK) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET

Company Participants

Marissa Bych - Investor Relations

Erica Rogers - Chief Executive Officer

Lucas Buchanan - Chief Financial Officer & Chief Operating Officer

Conference Call Participants

Chris Pasquale - Nephron Research

Rick Wise - Stifel

Neil Chatterji - B. Riley

Joanne Wuensch - Citi

Travis Steed - Bank of America Securities

Kristen Stewart - CL King

Adam Maeder - Piper Sandler

Michael Polark - Wolfe Research

Operator

Good afternoon and thank you for joining Silk Road Medical's Second Quarter 2023 Earnings Call. [Operator Instructions]

Now, I will turn the call over to Marissa Bych with Gilmartin Group for a few introductory comments.

Marissa Bych

Great and thank you for joining today's call. Joining me are Erica Rogers, Chief Executive Officer; and Lucas Buchanan, Chief Financial Officer and Chief Operating Officer. Earlier today, Silk Road Medical released financial results for the 3 months ended June 30, 2023. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of the federal securities laws which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements. All forward-looking statements including, without limitation, those relating to our operating trends and future financial performance, expense management, expectations for hiring and growth in our organization and our business, physician training and adoption, market opportunity and penetration, commercial and international expansion, regulatory approvals, reimbursement, competition and product development are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our latest quarterly report on Form 10-Q filed with the Securities and Exchange Commission. This conference call contains time-sensitive information and is accurate only as of the live broadcast today, August 1, 2023. Silk Road Medical disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise.